pubrio
Jacobio Pharma

Jacobio Pharma

China · Biotechnology Research

Research

Pharmaceuticals

Biotechnology

Health Care

Biotechnology Research

Jacobio Pharma (1167.HK) is committed to developing and providing new and innovative products and solutions to improve people's health. Our pipeline revolves around novel molecular targets on six major signalling pathways: KRAS, immune checkpoints, tumor metabolism, P53, RB and MYC. We aim for our key projects to be among the top three in the world. Our vision is to become a global leader recognized for our impact in drug R&D together with our partners. Jacobio has R&D centers in Beijing, Shanghai and Boston with our Induced Allosteric Drug Discovery Platform (IADDP) and our iADC Platform.

Company Insights
Company Overview

2015

Founded

Biotechnology Research

Industry

China

Location

2,930,486

Ranking

42 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Jacobio Pharma

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​